Cystic pancreatic neuroendocrine tumors: outcomes of preoperative endosonography-guided fine needle aspiration, and recurrence during long-term follow-up^[*]

 

 Buy Article Permissions and Reprints

Background and study aims: The role of endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) in the diagnosis and management of cystic pancreatic neuroendocrine tumors (PNETs) is unclear. We aimed to compare clinical/endosonographic characteristics of cystic with solid PNETs, determine diagnostic accuracy of preoperative EUS-FNA, and evaluate recurrence rates after resection.

Patients and methods: All patients with cystic or solid PNET confirmed by EUS-FNA between 2000 and 2014 were identified. A matched case-control study compared 50 consecutive patients with cystic PNETs with 50 consecutive patients with solid PNETs, matched by gender and age at diagnosis of index cystic PNET. We compared clinical/endosonographic characteristics, assessed diagnostic accuracy of preoperative EUS-FNA for identifying malignancy, and analyzed tumor-free survival of patients with cystic and solid PNETs.

Results: Cystic PNETs tended to be larger than solid PNETs (mean 26.8 vs. 20.1 mm, P = 0.05), more frequently nonfunctional (96 % vs. 80 %, P = 0.03), and less frequently associated with multiple endocrine neoplasia type 1 (10 % vs. 28 %, P = 0.04). With surgical pathology as reference standard, EUS-FNA accuracies for malignancy of cystic and solid PNETs were 89.3 % and 90 %, respectively; cystic PNETs were less associated with metastatic adenopathy (22 % vs. 42 %, P = 0.03) and liver metastasis (0 % vs. 26 %, P < 0.001). Cystic fluid analysis (n = 13), showed benign cystic PNETs had low carcinoembryonic antigen (CEA), Ki-67 ≤ 2 %, and no loss of heterozygosity. Patients with cystic and solid PNETs had similar recurrence risk up to 5 years after complete resection.

Conclusions: Cystic PNETs have distinct clinical and EUS characteristics, but were associated with less aggressive biological behavior compared with solid PNETs. EUS-FNA is accurate for determining malignant potential on preoperative evaluation. Despite complete resection, recurrence is observed up to 5 years following surgery.

^* An earlier version of the abstract was presented at Digestive Disease Week (DDW), 18 – 21 May 2013, Orlando, Florida, USA.

^** W. Ridtitid and H. Halawi contributed equally to this study.

• References

• 1 Pais SA, Al-Haddad M, Mohamadnejad M et al. EUS for pancreatic neuroendocrine tumors: a single-center, 11-year experience. Gastrointest Endosc 2010; 71: 1185-1193
  CrossrefPubMedGoogle Scholar
• 2 Kongkam P, Al-Haddad M, Attasaranya S et al. EUS and clinical characteristics of cystic pancreatic neuroendocrine tumors. Endoscopy 2008; 40: 602-605
  Article in Thieme ConnectPubMedGoogle Scholar
• 3 Goldstone AP, Scott-Coombes DM, Lynn JA. Surgical management of gastrointestinal endocrine tumours. Bailliere’s Clin Gastroenterol 1996; 10: 707-736
  PubMedGoogle Scholar
• 4 Lee LC, Grant CS, Salomao DR et al. Small, nonfunctioning, asymptomatic pancreatic neuroendocrine tumors (PNETs): role for nonoperative management. Surgery 2012; 152: 965-974
  CrossrefPubMedGoogle Scholar
• 5 Figueiredo FA, Giovannini M, Monges G et al. EUS-FNA predicts 5-year survival in pancreatic endocrine tumors. Gastrointest Endosc 2009; 70: 907-914
  CrossrefPubMedGoogle Scholar
• 6 Rustagi T, Farrell JJ. Endoscopic diagnosis and treatment of pancreatic neuroendocrine tumors. J Clin Gastroenterol 2014; 48: 837-844 Epub: May 16 2014
  PubMedGoogle Scholar
• 7 Jani N, Khalid A, Kaushik N et al. EUS-guided FNA diagnosis of pancreatic endocrine tumors: new trends identified. Gastrointest Endosc 2008; 67: 44-50
  CrossrefPubMedGoogle Scholar
• 8 Chatzipantelis P, Salla C, Konstantinou P et al. Endoscopic ultrasound-guided fine-needle aspiration cytology of pancreatic neuroendocrine tumors: a study of 48 cases. Cancer 2008; 114: 255-262
  CrossrefPubMedGoogle Scholar
• 9 Ardengh JC, de Paulo GA, Ferrari AP. EUS-guided FNA in the diagnosis of pancreatic neuroendocrine tumors before surgery. Gastrointest Endosc 2004; 60: 378-384
  CrossrefPubMedGoogle Scholar
• 10 Alsohaibani F, Bigam D, Kneteman N et al. The impact of preoperative endoscopic ultrasound on the surgical management of pancreatic neuroendocrine tumours. Can J Gastroenterol 2008; 22: 817-820
  PubMedGoogle Scholar
• 11 Baker MS, Knuth JL, DeWitt J et al. Pancreatic cystic neuroendocrine tumors: preoperative diagnosis with endoscopic ultrasound and fine-needle immunocytology. J Gastrointest Surg 2008; 12: 450-456
  CrossrefPubMedGoogle Scholar
• 12 Puli SR, Kalva N, Bechtold ML et al. Diagnostic accuracy of endoscopic ultrasound in pancreatic neuroendocrine tumors: a systematic review and meta analysis. World J Gastroenterol 2013; 19: 3678-3684
  CrossrefPubMedGoogle Scholar
• 13 Atiq M, Bhutani MS, Bektas M et al. EUS-FNA for pancreatic neuroendocrine tumors: a tertiary cancer center experience. Dig Dis Sci 2012; 57: 791-800
  CrossrefPubMedGoogle Scholar
• 14 Ho HC, Eloubeidi MA, Siddiqui UD et al. Endosonographic and cyst fluid characteristics of cystic pancreatic neuroendocrine tumours: a multicentre case series. Dig Liver Dis 2013; 45: 750-753
  CrossrefPubMedGoogle Scholar
• 15 Yoon WJ, Daglilar ES, Pitman MB et al. Cystic pancreatic neuroendocrine tumors: endoscopic ultrasound and fine-needle aspiration characteristics. Endoscopy 2013; 45: 189-194
  Article in Thieme ConnectPubMedGoogle Scholar
• 16 Goh BK, Ooi LL, Tan YM et al. Clinico-pathological features of cystic pancreatic endocrine neoplasms and a comparison with their solid counterparts. Eur J Surg Oncol 2006; 32: 553-556
  CrossrefPubMedGoogle Scholar
• 17 Gaujoux S, Tang L, Klimstra D et al. The outcome of resected cystic pancreatic endocrine neoplasms: a case-matched analysis. Surgery 2012; 151: 518-525
  CrossrefPubMedGoogle Scholar
• 18 Ogura T, Yamao K, Sawaki A et al. Clinical impact of K-ras mutation analysis in EUS-guided FNA specimens from pancreatic masses. Gastrointest Endosc 2012; 75: 769-774
  CrossrefPubMedGoogle Scholar
• 19 Collins BT, Cramer HM. Fine-needle aspiration cytology of islet cell tumors. Diagn Cytopathol 1996; 15: 37-45
  CrossrefPubMedGoogle Scholar
• 20 Larghi A, Capurso G, Carnuccio A et al. Ki-67 grading of nonfunctioning pancreatic neuroendocrine tumors on histologic samples obtained by EUS-guided fine-needle tissue acquisition: a prospective study. Gastrointest Endosc 2012; 76: 570-577
  CrossrefPubMedGoogle Scholar
• 21 Rindi G, Kloppel G, Alhman H et al. TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch 2006; 449: 395-401
  CrossrefPubMedGoogle Scholar
• 22 Koh YX, Chok AY, Zheng HL et al. A systematic review and meta-analysis of the clinicopathologic characteristics of cystic versus solid pancreatic neuroendocrine neoplasms. Surgery 2014; 156: 83-96 e82
  CrossrefPubMedGoogle Scholar
• 23 Singhi AD, Chu LC, Tatsas AD et al. Cystic pancreatic neuroendocrine tumors: a clinicopathologic study. Am J Surg Pathol 2012; 36: 1666-1673
  CrossrefPubMedGoogle Scholar
• 24 Boninsegna L, Partelli S, D'Innocenzio MM et al. Pancreatic cystic endocrine tumors: a different morphological entity associated with a less aggressive behavior. Neuroendocrinology 2010; 92: 246-251
  CrossrefPubMedGoogle Scholar
• 25 Charfi S, Marcy M, Bories E et al. Cystic pancreatic endocrine tumors: an endoscopic ultrasound-guided fine-needle aspiration biopsy study with histologic correlation. Cancer 2009; 117: 203-210
  PubMedGoogle Scholar
• 26 Fasanella KE, McGrath KM, Sanders M et al. Pancreatic endocrine tumor EUS-guided FNA DNA microsatellite loss and mortality. Gastrointest Endosc 2009; 69: 1074-1080
  CrossrefPubMedGoogle Scholar
• 27 Croagh D, Forde C, Boulton R et al. Cyst fluid carcinoembryonic antigen in the investigation of cystic neuroendocrine tumors of the pancreas. Gastrointest Endosc 2011; 74: 1413-1416
  CrossrefPubMedGoogle Scholar
• 28 Bosman FT. World Health Organization, International Agency for Research on Cancer. WHO classification of tumours of the digestive system. 4th. edn. Lyon: IARC Press; 2010
  Google Scholar
• 29 Hasegawa T, Yamao K, Hijioka S et al. Evaluation of Ki-67 index in EUS-FNA specimens for the assessment of malignancy risk in pancreatic neuroendocrine tumors. Endoscopy 2014; 46: 32-38
  Article in Thieme ConnectPubMedGoogle Scholar
• 30 Beane JD, House MG, Cote GA et al. Outcomes after preoperative endoscopic ultrasonography and biopsy in patients undergoing distal pancreatectomy. Surgery 2011; 150: 844-853
  CrossrefPubMedGoogle Scholar
• 31 Inchauste SM, Lanier BJ, Libutti SK et al. Rate of clinically significant postoperative pancreatic fistula in pancreatic neuroendocrine tumors. World J Surg 2012; 36: 1517-1526
  CrossrefPubMedGoogle Scholar
• 32 Levy MJ, Gleeson FC, Campion MB et al. Prospective cytological assessment of gastrointestinal luminal fluid acquired during EUS: a potential source of false-positive FNA and needle tract seeding. Am J Gastroenterol 2010; 105: 1311-1318
  CrossrefPubMedGoogle Scholar
• 33 Yoon WJ, Daglilar ES, Fernandez-del Castillo C et al. Peritoneal seeding in intraductal papillary mucinous neoplasm of the pancreas patients who underwent endoscopic ultrasound-guided fine-needle aspiration: the PIPE Study. Endoscopy 2014; 46: 382-387
  Article in Thieme ConnectPubMedGoogle Scholar
• 34 El Chafic AH, Dewitt J, Leblanc JK et al. Impact of preoperative endoscopic ultrasound-guided fine needle aspiration on postoperative recurrence and survival in cholangiocarcinoma patients. Endoscopy 2013; 45: 883-889
  Article in Thieme ConnectPubMedGoogle Scholar